Nathan Vardi

For most financiers, “government” is a four-letter word. But private equity billionaire Ramzi Musallam has turned tragedy into a Forbes 400 fortune by distilling the motivations of the largest player in the global economy.

Five years ago trans whistleblower Chelsea Manning sketched out a new way to protect online privacy from her prison cell. Venture-backed Nym Network just hired her to break into their blockchain version of her plan.

LeBron James has earned more than $1 billion during his 18-year career, with nearly $400 million in salary and some $600 million in off-court earnings, but that doesn’t make him a billionaire.

The entrepreneur behind $1 billion company hit with U.S. sanctions insists he just wants to help protect all companies from hackers. U.S. security officials don’t buy it.

Covid’s Forgotten Hero: The Untold Story Of The Scientist Whose Breakthrough Made The Vaccines Possible

Valuations for entertainment’s hottest production companies are already soaring and the deal makers are just getting started.

As calls for taxes on the super-rich grow louder, Wall Street’s smartest dealmakers have quietly discovered a new way to unlock value and circumvent taxes. It’s minting buyout billionaires by the dozen

Millennials are reshaping Wall Street and the changing contours of finance means this year’s 30 Under 30 Finance list is hands-down Forbes’ most diverse. Some 40% of list-makers are female, and nearly a quarter emigrated to the United States.

The man behind one of the biggest social media stock market debacles is trying to increase his shares in SoFi, where he is a director.

Vadim Pereleman’s Baker Street hedge fund made Walter Investment Management the only holding in its U.S. stock portfolio. The stock has plunged by 95% since Baker Street became Walter Investment Management’s biggest shareholder.

Caterpillar SARL was created in 1999 and the feds are investigating how Caterpillar used the affiliate to lower its U.S. tax bill.

#1341 Osman Kibar on the 2022 Billionaires - Osman Kibar is the founder and CEO of San Diego-based biotech firm Samumed. Samumed raised $438 million in August 2018 to further its work developing drugs to reverse aging, claiming a valuation of $12.4 billion.

Backed by world-class science, a stealthy biotech has raised $1.9 billion by promising to change medicine forever. A new lawsuit opens a rare window into its secrets.

#1645 Edward Lampert on the 2022 Billionaires - After a stint at Goldman Sachs’ risk arbitrage department, Edward Lampert founded hedge fund ESL Investments in 1988, betting on undervalued stocks. He took over as CEO of struggling retail giant Sears Holdings (Sears, Kmart, Kenmore) in 2013 with hope…

#87 David Shaw on the 2022 Forbes 400 - A former computer science professor at Columbia University, David Shaw is the founder of D.E. Shaw, which manages

In less than a year, valeant pharmaceuticals has lost 87% of its value--some $80 billion--amid accusations of mismanagement and financial shenanigans. The inside story reveals a pressure cooker that was built to explode.

Markets around the world are reeling in early 2016. These are the facts and figures you need to know about China, oil prices and the big stock selloff.

Advice on stocks, bonds, retirement, taxes and real estate you can act on today. Plus, a look at the fintech start-ups changing how you’ll save, invest, spend and borrow tomorrow.

George Soros, John Paulson and Leon Cooperman have secretly moved into battle mode against Sheldon Adelson. The stakes: the future of gambling in America.

Mark Rachesky makes billions for his investors by grabbing control of companies like Lions Gate Entertainment on the cheap.